FR2919185B1 - Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses - Google Patents

Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses

Info

Publication number
FR2919185B1
FR2919185B1 FR0705349A FR0705349A FR2919185B1 FR 2919185 B1 FR2919185 B1 FR 2919185B1 FR 0705349 A FR0705349 A FR 0705349A FR 0705349 A FR0705349 A FR 0705349A FR 2919185 B1 FR2919185 B1 FR 2919185B1
Authority
FR
France
Prior art keywords
preparation
condition
improve
hyaluronic acid
mucous membranes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0705349A
Other languages
English (en)
French (fr)
Other versions
FR2919185A1 (fr
Inventor
Anthony Bresin
Edith Puchelle
Jean Marie Zahm
Magali Milliot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Agro Industrie Recherches et Developpements ARD
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Agro Industrie Recherches et Developpements ARD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0705349A priority Critical patent/FR2919185B1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Agro Industrie Recherches et Developpements ARD filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to US12/670,219 priority patent/US8895532B2/en
Priority to EP08827623.3A priority patent/EP2167102B1/fr
Priority to CN2008801063138A priority patent/CN101801391B/zh
Priority to HK10111724.8A priority patent/HK1145149B/xx
Priority to ES08827623.3T priority patent/ES2588190T3/es
Priority to JP2010517434A priority patent/JP2010534225A/ja
Priority to BRPI0814446-0A2A priority patent/BRPI0814446A2/pt
Priority to KR1020107001664A priority patent/KR20100059786A/ko
Priority to PCT/FR2008/000959 priority patent/WO2009024677A2/fr
Publication of FR2919185A1 publication Critical patent/FR2919185A1/fr
Application granted granted Critical
Publication of FR2919185B1 publication Critical patent/FR2919185B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Otolaryngology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR0705349A 2007-07-23 2007-07-23 Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses Active FR2919185B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0705349A FR2919185B1 (fr) 2007-07-23 2007-07-23 Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
KR1020107001664A KR20100059786A (ko) 2007-07-23 2008-07-04 특히 피부, 눈, 및 점막 보호기능의 향상을 위하여 의도된 조성물의 제조를 위한 히알루론산의 용도
CN2008801063138A CN101801391B (zh) 2007-07-23 2008-07-04 透明质酸在制备用于改善皮肤、眼和粘膜的保护功能的组合物中的用途
HK10111724.8A HK1145149B (en) 2007-07-23 2008-07-04 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection
ES08827623.3T ES2588190T3 (es) 2007-07-23 2008-07-04 Utilización de ácido hialurónico para la preparación de composiciones destinadas a la mejora de la función de protección de la piel, del ojo y de las mucosas
JP2010517434A JP2010534225A (ja) 2007-07-23 2008-07-04 皮膚、眼および粘膜の保護機能改善用組成物を製造するためのヒアルロン酸の使用
US12/670,219 US8895532B2 (en) 2007-07-23 2008-07-04 Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes
EP08827623.3A EP2167102B1 (fr) 2007-07-23 2008-07-04 Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration de la fonction de protection de la peau, de l'oeil et des muqueuses
PCT/FR2008/000959 WO2009024677A2 (fr) 2007-07-23 2008-07-04 Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de la fonction de protection de la peau, de l'oeil et des muqueuses
BRPI0814446-0A2A BRPI0814446A2 (pt) 2007-07-23 2008-07-04 Uso de ácido hialurônico para o preparo de composições destinadas a melhorar notadamente a função de proteção da pele, de olho e das mucosas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0705349A FR2919185B1 (fr) 2007-07-23 2007-07-23 Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses

Publications (2)

Publication Number Publication Date
FR2919185A1 FR2919185A1 (fr) 2009-01-30
FR2919185B1 true FR2919185B1 (fr) 2010-09-10

Family

ID=39088885

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0705349A Active FR2919185B1 (fr) 2007-07-23 2007-07-23 Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses

Country Status (9)

Country Link
US (1) US8895532B2 (https=)
EP (1) EP2167102B1 (https=)
JP (1) JP2010534225A (https=)
KR (1) KR20100059786A (https=)
CN (1) CN101801391B (https=)
BR (1) BRPI0814446A2 (https=)
ES (1) ES2588190T3 (https=)
FR (1) FR2919185B1 (https=)
WO (1) WO2009024677A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010003797A1 (en) * 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
KR102238406B1 (ko) 2011-06-03 2021-04-08 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
ES2667854T3 (es) * 2011-07-07 2018-05-14 Holy Stone Healthcare Co., Ltd. Composición para uso en el tratamiento y la prevención de trastornos relacionados con la inflamación
TWI466675B (zh) 2011-09-16 2015-01-01 Univ China Medical 用於抑制發炎之醫藥組合物
CN102669681A (zh) * 2012-06-09 2012-09-19 东莞市照燕生物科技有限公司 一种保护胃肠粘膜的营养保健品
ES2627868T3 (es) 2012-10-25 2017-07-31 Mdt Int'l S.A. Composiciones mucoadhesivas que comprenden ácido hialurónico y quitosano para aplicación tópica
JP2015063510A (ja) * 2013-06-28 2015-04-09 キユーピー株式会社 肌の保湿機能向上に関わる保湿関連遺伝子発現促進剤
EP3328353B1 (en) 2015-07-27 2024-04-10 Mary Kay, Inc. Topical skin formulations
JP6718728B2 (ja) * 2016-04-06 2020-07-08 キユーピー株式会社 アンチポリューション剤およびアンチポリューション用皮膚外用組成物
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
CN115317504A (zh) * 2021-05-10 2022-11-11 傅毓秀 玻尿酸用于制备治疗急性呼吸窘迫症药剂的用途
WO2022236599A1 (zh) * 2021-05-10 2022-11-17 傅毓秀 玻尿酸用于制备治疗急性呼吸窘迫症药剂的用途
WO2022236585A1 (zh) * 2021-05-10 2022-11-17 傅毓秀 玻尿酸用于制备治疗肺纤维化药剂的用途
TWI816119B (zh) * 2021-05-10 2023-09-21 國立陽明交通大學 玻尿酸用於製備治療急性呼吸窘迫症藥劑之用途
WO2023079072A1 (en) 2021-11-05 2023-05-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof
EP4683647A1 (en) * 2023-03-22 2026-01-28 Institut National de la Santé et de la Recherche Médicale Use of low molecular weight hyaluronic acid for promoting ciliated cell differentiation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
JPS59219209A (ja) * 1983-05-28 1984-12-10 Kanebo Ltd 皮膚化粧料
IT1260148B (it) * 1992-04-17 1996-03-28 Fidia Spa Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
DE10111165A1 (de) * 2001-03-02 2002-10-10 Knoell Hans Forschung Ev Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen
DE10161149B4 (de) 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
DE10161110A1 (de) 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
US7241456B2 (en) * 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
FR2847818B1 (fr) * 2002-11-28 2008-04-04 Agro Ind Rech S Et Dev Ard Composition pharmaceutique a base d'acide hyaluronique
CN101123942A (zh) * 2005-01-03 2008-02-13 诺维信生物聚合物公司 具有保湿和抗皱纹性质的透明质酸级分
JP4576583B2 (ja) * 2005-03-22 2010-11-10 キユーピー株式会社 ヒアルロン酸またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物

Also Published As

Publication number Publication date
EP2167102A2 (fr) 2010-03-31
JP2010534225A (ja) 2010-11-04
BRPI0814446A2 (pt) 2015-01-06
EP2167102B1 (fr) 2016-05-25
FR2919185A1 (fr) 2009-01-30
US20100210585A1 (en) 2010-08-19
CN101801391B (zh) 2013-07-10
WO2009024677A3 (fr) 2009-12-03
KR20100059786A (ko) 2010-06-04
ES2588190T3 (es) 2016-10-31
HK1145149A1 (en) 2011-04-08
US8895532B2 (en) 2014-11-25
WO2009024677A2 (fr) 2009-02-26
CN101801391A (zh) 2010-08-11

Similar Documents

Publication Publication Date Title
FR2919185B1 (fr) Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
EP2005957A4 (en) acid secretion
EP2195348A4 (en) PREPARATION OF HYALURONIC ACID
EP2464626A4 (en) PROCESSES, COMPOUNDS AND COMPOSITIONS FOR THE EXPORTS OF 1,3-PROPANE-SULFONIC ACID
IL217828B (en) Crystalline molecular complex consisting of zeldronate acid, lysine and water, pharmaceutical compositions containing it and uses thereof
EP2265709A4 (en) MICRO-ORGANISMS FOR THE PREPARATION OF ADIPINIC ACID AND OTHER COMPOUNDS
FR2917969B1 (fr) Utilisation cosmetique d'un derive d'acide imido-percarboxylique a titre d'agent desquamant
EP2458996A4 (en) NEW ORAL FORMS OF PHOSPHONIC ACID DERIVATIVE
EP2552216A4 (en) DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID
EP2714718A4 (en) HYALURONIC ACID BINDING SYNTHETIC PEPTIDOGLYCANES, THEIR PREPARATION AND METHOD FOR THEIR USE
BRPI0819423A2 (pt) "lenço auto-indicador para remover bactérias de uma superfície"
FR2918876B1 (fr) Utilisation de lumiere verte pour activer la l-amino acide oxydase
FR2909999B1 (fr) Procede de preparation d'acide acrylique a partir de glycerol
FR2950247B1 (fr) Utilisation de l'acide ascorbique pour deformer des fibres keratiniques
FR2954123B1 (fr) Composition cosmetique de nettoyage comprenant un derive d'acide jasmonique et un tensioactif
FR2902324B1 (fr) Utilisation d'acide ellagique pour le traitement de la canitie
EP2501371A4 (en) USE OF HYDROXYTYROSOL FOR IMPROVED MUSCLE DIFFERENTIATION
EP2006331A4 (en) polylactic acid
EP2417168A4 (en) PHOSPHORIC ACIDIC POLYMALEIMIDE PREPOLYMER COMPOSITIONS
FR2924115B1 (fr) Procede de preparation d'un acide trifluoromethanesulfinique
EP2032526A4 (en) UNSATURATED ALKYL ESTERS FROM 5-AMINOLEVULINIC ACID AND THEIR PREPARATION AND USE
EP3138850B8 (en) Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid
FR2956808B1 (fr) Utilisation de l'acide ellagique comme agent anti-pelliculaire.
PL2409698T3 (pl) Zastosowanie kwasu indazolometoksyalkanowego do wytwarzania kompozycji farmaceutycznej
EP2576437A4 (en) POLYPHOSPHORIC ACID COMPOSITIONS WITH REDUCED VISCOSITY

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19